Aurora Cannabis (NASDAQ:ACB) Downgraded by Wall Street Zen to Sell

Aurora Cannabis (NASDAQ:ACB - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Friday.

Aurora Cannabis Price Performance

NASDAQ ACB traded up $0.09 during mid-day trading on Friday, hitting $4.24. The stock had a trading volume of 1,361,752 shares, compared to its average volume of 1,570,819. Aurora Cannabis has a 52-week low of $3.42 and a 52-week high of $7.20. The company has a market cap of $238.33 million, a price-to-earnings ratio of 69.17 and a beta of 1.82. The company has a 50 day simple moving average of $5.03 and a 200 day simple moving average of $4.73. The company has a quick ratio of 2.16, a current ratio of 4.31 and a debt-to-equity ratio of 0.13.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last released its quarterly earnings data on Wednesday, June 18th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.04). Aurora Cannabis had a net margin of 1.32% and a return on equity of 0.13%. The firm had revenue of $63.34 million during the quarter, compared to analysts' expectations of $88.85 million. Equities analysts forecast that Aurora Cannabis will post 0.46 EPS for the current fiscal year.

Hedge Funds Weigh In On Aurora Cannabis

Several hedge funds have recently bought and sold shares of ACB. SBI Securities Co. Ltd. purchased a new position in Aurora Cannabis during the fourth quarter worth $31,000. Susquehanna Fundamental Investments LLC acquired a new stake in shares of Aurora Cannabis during the fourth quarter worth $45,000. JW Asset Management LLC acquired a new stake in shares of Aurora Cannabis during the first quarter worth $58,000. Cobblestone Asset Management LLC acquired a new stake in shares of Aurora Cannabis during the first quarter worth $67,000. Finally, Millennium Management LLC acquired a new stake in shares of Aurora Cannabis during the fourth quarter worth $67,000. Hedge funds and other institutional investors own 47.63% of the company's stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.